SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-254142
Filing Date
2021-08-23
Accepted
2021-08-23 17:27:04
Documents
14
Period of Report
2021-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d215509d8k.htm   iXBRL 8-K 29699
2 EX-10.1 d215509dex101.htm EX-10.1 653272
  Complete submission text file 0001193125-21-254142.txt   878057

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arpo-20210817.xsd EX-101.SCH 2759
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20210817_def.xml EX-101.DEF 13034
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20210817_lab.xml EX-101.LAB 21689
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20210817_pre.xml EX-101.PRE 13822
7 EXTRACTED XBRL INSTANCE DOCUMENT d215509d8k_htm.xml XML 4797
Mailing Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140
Business Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 211197845
SIC: 2834 Pharmaceutical Preparations